exhibition pictures

Basic Info

Product Description

Ornidazole Injection

Product Name: Ornidazole Injection

Main Ingredients and Chemical Name: Ornidazole

Character: The product is a slightly yellow-green to yellow-green clear liquid.

Indication:

1. The product is indicated for the treatment of severe intestinal and hepatic amoebiasis.
2. It is indicated for the treatment of postoperative infection caused by ormidazole sensitive anaerobic bacteria.
3. It is indicated for the prevention of sensitive anaerobic bacterial infection caused by surgery.

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in the Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company mainly specializes in R&D, manufacture, and sales of a wide range of drugs, mainly including intravenous infusions. The production lines have achieved full automation control and information control in the production process and logistics process, reaching international advanced levels by integrating world-leading equipment and technology. With product quality as its life, the company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures, and provides guarantees for the health of patients at home and abroad with excellent quality products and services. The company has a powerful R&D team and has made a number of achievements in scientific research, undertaking many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment, and accelerating the pace of technological innovation. Large volume injection is the key product, along with tablets, capsules, small volume injection, and other forms are also manufactured. Recently, API has been put into production and sales. There are more than ten international advanced production lines for large volume injection, and its production scale, technology level, brand influence, and economic benefits are among the top of domestic counterparts. It has become one of China's Top 100 Pharmaceutical Industry Enterprises and one of China's Top 10 Chemical and Pharmaceutical Industry Preparation Export-Oriented Excellent Enterprise Brands for many consecutive years. The products are distributed across all provinces, autonomous regions, and municipalities in China and are also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa, and other continents, becoming one of the main export enterprises of infusion products.